Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
The American Journal of Pathology|December 7, 2000
Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotypeS L Pender, M T Salmela, G Monteleone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profileS Nagata, C McKenzie, S L Pender, et al.
Mucosal Immunology|May 26, 2016
Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel diseaseE M Giles, T J Sanders, N E McCarthy, et al.
Pediatric Research|October 1, 1995
Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton ratsP R Wyde, D K Moore, T Hepburn, et al.
Lancet (London, England)|November 2, 1991
Immediate hypersensitivity in colon of children with chronic Trichuris trichiura dysenteryE S Cooper, J Spencer, C A Whyte-Alleng, et al.
Journal of Clinical Pathology|March 1, 1991
Histopathology and immunohistochemistry of the caecum in children with the Trichuris dysentery syndromeT T MacDonald, M Y Choy, J Spencer, et al.
Gut|January 8, 2008
Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosaA Di Sabatino, K M Pickard, D Rampton, et al.
Journal of Crohn'S & Colitis|December 22, 2010
CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel diseaseJ N Gordon, J D Prothero, C A Thornton, et al.
Gastroenterology|June 1, 1994
Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel diseaseE J Breese, C A Michie, S W Nicholls, et al.
The Journal of Infectious Diseases|June 3, 1999
A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9S Johnson, S D Griego, D S Pfarr, et al.
Pageof 20